Table 3.
Logistic regression analyses to predict cases in the small PA lesion group
| Crude | Adjusted | ||||||
|---|---|---|---|---|---|---|---|
| Variables | Odds ratio | 95% confidence interval | p value | Odds ratio | 95% confidence interval | p value | |
| Test cohort | Intensity of antihypertensives | 0.645 | (0.389–1.071) | 0.09 | |||
| (Small PA lesion group/total = 27/112) | Serum K level (mEq/L) | 5.877 | (1.928–17.911) | 0.002 | 6.277 | (2.081–18.934) | 0.001 |
| PAC | 0.994 | (0.989–1.000) | 0.037 | 0.994 | (0.989–1.000) | 0.037 | |
| Validation cohort | Intensity of antihypertensives | 0.921 | (0.573–1.479) | 0.73 | |||
| (Small PA lesion group/total = 20/105) | Serum K level (mEq/L) | 5.072 | (1.493–17.231) | 0.009 | 6.601 | (2.214–19.681) | <0.001 |
| PAC | 0.998 | (0.994–1.003) | 0.41 | ||||
CT computed tomography, PAC plasma aldosterone concentration (pg/mL), ARR aldosterone-renin ratio